Compounds > 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Leukemia, Megakaryoblastic, Acute

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Leukemia, Megakaryoblastic, Acute in 1 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Leukemia, Megakaryoblastic, Acute: An acute myeloid leukemia in which 20-30% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. MYELOFIBROSIS or increased bone marrow RETICULIN is common.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhan, M1
Han, ZC1

Other Studies

1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Leukemia, Megakaryoblastic, Acute

ArticleYear
Hemangiopoietin inhibits apoptosis of MO7e leukemia cells through phosphatidylinositol 3-kinase-AKT pathway.
    Biochemical and biophysical research communications, 2004, Apr-23, Volume: 317, Issue:1

    Topics: Androstadienes; Apoptosis; bcl-Associated Death Protein; Carrier Proteins; Caspase Inhibitors; Cell

2004